Non small cell lung cancer - Comparison between clinical and pathological staging;Cancro do pulmão de não pequenas células - Comparação entre o estadiamento clínico e o patológico

Revista Portuguesa de Pneumologia

Volumn 12, Issue 4, 2006, Pages 337-357

  Fernades, Gabriela ^a   Sucena, M ^c   Lombardia, E ^c   Machado, A ^c   Hespanhol, V ^c   Queiroga, H ^c   Marques, J Agostinho ^b  

^a HOSPITAL DE SÃO JOÃO   (Portugal)

^b University of Porto   (Portugal)

^c NONE

Author keywords

Clinical staging; Lung cancer; Pathological staging

Indexed keywords

ACCURACY; ADULT; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PROGNOSIS; RETROSPECTIVE STUDY; THORACOTOMY;

EID: 33748749623     PISSN: 08732159     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0873-2159(15)30438-4     Document Type: Article

References (37)

1. Mountain CF. Revisions in the international system for staging lung cancer Chest 1997; 111:1710-7.
2. Spiro S. Management of lung cancer. Remains surgery for cure of non-small cell and chemotherapy for small cell type. BMJ 1990; 301:1287-8.
3. Damhuis AM, Schutte PR. Resection rates and postoperative mortality in 7899 patients with lung cancer. Eur Resp J 1996; 9:7-10.
4. Verschakelen JA, Boagaert J, De Wever W. Computed tomography in staging for lung cancer. Eur Resp J 2002; 19:Suppl. 35,40-48s.
5. Schaefer-Prokop, Prokop M. New imaging techniques in the treatment guidelines for lung cancer. Eur Resp J 2002; 19(Suppl 35): 71-83s.
6. Barker JM, Silvestri GA. Lung cancer staging. Curr Opin Pulm Med 2002; 8:287-293.
7. Deslauriers J, Grégoire J. Clinical and surgical staging of non-small cell lung cancer. Chest 2000; 117:96s-103s.
8. Patz EF Jr. Imaging bronchogenic carcinoma. Chest 2000; 117:90-95s.
9. Toloza EM, Harpole L, McCrory DC. Non invasive staging of non-small cell lung cancer- a review of the current evidence. Chest 2003; 123:137s-146s.
10. a JM Gomes, R Sotto Mayor eds.). Tratado de Pneumologia. VoL II, Lisboa, SPP, pp 1149-1167.
11. Silvestri GA, Littenberg B, Colice GL: The clinical evaluation for detecting metastatic lung cancer: a meta-analysis. Am J Respir Crit Care Med 1995; 152:714-719.
12. Gerard A, Silvestri, Lynn TT, Margolis LM, Barker J, Deterbeck F: The Noninvasive Staging of Non-small Cell Lung Cancer. The guidelines. Chest 2003; 147s-156s.
13. Spiro SG, Porter J. Lung cancer - where we are today? Current advances in staging and nonsurgical treatment. Am J Respir Crit Care Med 2002; 166:1166-1196.
14. Antoch G, Stattaus J, Nemat AT, Marnitz S, Beyer T, Kuehl H, Bockisch A, Debatin J, Freudenberg L. Non-small cell lung cancer: dual-modality PET/ CT in preoperative staging. Radiology 2003; 229:526-533.
15. Lardinois D, Weder W, Hany, T, Kamel E, Korom S, Seifert B, Schulthess, Steiner HC. Staging of non-small-cell-lung-cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 2003; 348:2500-7.
16. Pieterman RM, Van Putten WG, Neuzelaar JJ, Mooyaart EL, Vaalburg W, Koeter G, Fidler V, Pruim J, Groen HJM. Preoperative staging of non small-cell lung cancer with positron - emission tomography. N Engl J Med 2000; 343:54-61.
17. Kelly RF, Tran T, Holmstrom A, Murar J, Segurola RJ. Accurary and cost-effectiveness of (18F)-2-fluoro-deoxy-D-glucose-positron emission tomography scan in potentially respectable non-small cell lung cancer. Chest 2004; 125(4):1413-23.
18. Detterbeck FC, Falen S, Rivera MP, Halle Jan, Socinski MA. Seeking a home for a PET, Part 2. Defining the appropriate place for positron emission tomography imaging in the staging of patients with suspected lung cancer. Chest 2004; 125:2300-2308.
19. Travis WD, et al. Histological typing of lung and pleural tumours (3.a Ed.). World Health Organization. Springer.
20. Oken MM, Creech RH, Torney DC et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982; 5:649-55.
21. Sucena M, Fernandes G, Queiroga H, Hespanhol V. Cancro do pulmão - O que mudou em duas décadas. Rev Port Pneumol 2005; XI(2):135-154.
22. Montero C, Rosales M, Otero I, Blanco M, Rodriguez G, Peterga S, Pita S, Verea H. cancer de pulmon en el área sanitária de A. Coruna: incidência, abordale clinico y supervivencia. Arch Bronconeumol 2003; 39(5):209-16.
23. Fergusson RJ, Gregor A, Dodds R, Kerr G. Management of lung cancer in South East Scotland. Thorax 1996; 51:569-574.
24. Yang et al. Clinical features of 5628 primary lung cancer patients. Experience at Mayo Clinic from 1997 to 2003. Chest 2005; 128:452-462.
25. Cetinkaya E, Turna A, Yildiz P, Dodurgali R, Bedirhan MA, Gurses A, Yilmaz V. Comparison of clinical and surgical-pathologic staging of the patients with non-small cell lung carcinoma. Eur J Cardiothoracic Surg 2002; 22(6):1000-5.
26. Gdeedo A, Van Schill P, Corthouts B, Van Mieghem F, Van Meerbeeck J, Van Marck E. Comparison of imaging TNM [(i) TNM] and pathological TNM [pTNM] in staging bronchogenic carcinoma. Eur J Cardiothoracic Surg 1997; 12(2):224-7.
27. Lewis JW Jr, Pearlberg JL, Beute GH, Alpern M, Kvale PA, Gross BH, Magilligan DJ Jr. Can computed tomography of the chest stage lung cancer? Yes and no. Ann Thorac Surg 1990; 49(4):591-5.
28. Fernando HC, Goldstraw P. The accuracy of clinical evaluative intrathoracic staging in lung cancer as assessed by postsurgical pathologic staging. Cancer 1990; 65(11):2503-6.
29. Sioris T, Jarvenpaa R, Kuukasjarvi P, Helin H, Saarelainen S, Tarkka M. Comparison of computed tomography and systematic lymph node dissection in determining TNM and stage in non-small cell lung cancer. Eur J Cardiothorac Surg 2003; 2(3):403-8.
30. Eggeling S, Martin T, Bottger J, Gellert K. Invasive staging of non-small cell lung cancer - a prospective study. Eur J Cardiothorac Surg 2002; 22(5):679-84.
31. Diagnosis and management of lung cancer: ACCP evidence-based guidelines. Chest 2003; 123(Suppl): 181-220s.
32. Sotto-Mayor R. Terapêutica do carcinoma pulmonar não de pequenas células. Rev Port Pneumol 2002; VIII(3):237-59.
33. Reif MS, Socinsky MA, Rivera MP. Evidence-based medicine in the treatment of non-small-cell lung cancer. Clin in Chest Med 2000; 21(1):107-120.
34. Winton et al. Vinorelbine plus cisplatin vs. observation in resected non-small cell lung cancer. N Engl J Med 2005; 352:2589-97.
35. Strauss GM. Role of chemotherapy in stages I to III Non-small cell lung cancer. Chest 1999; 116:509s-516s.
36. Laroche C, Wells F, Coulden R, Stewart S, Goddard M, Lowry E, Price A, Gilligan D. Improving surgical resection rate in king cancer. Thorax 1998; 53:445-449.
37. Makitaro R, Paakko P, Huhti E, Bloigu R, Kinnula VL. Prospective population-based study n the survival of patients with lung cancer. Eur Resp J 2002; 19:1087-1092.